MetaCap

LB Pharmaceuticals (LBRX) Stock Chart

NASDAQ: LBRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

38.85-1.19 (-2.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LBRX technical summary

LBRX is trading 1.6% below its 50-day simple moving average of $39.49 and 14.1% above its 200-day average of $34.04. The 50-day average is above the 200-day average, a configuration technical analysts associate with a longer-term uptrend. The 14-day Relative Strength Index (RSI) is 43.8, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $15.19 (Nov 21, 2025) to $50.16 (Aug 25, 2026); the current price sits 68% of the way from the low to the high. Annualized 30-day volatility is 63.5%. Based on the last session's high, low and close, the classic pivot point is $39.36, with first resistance at $40.16 and first support at $38.06.

These indicators describe past price behavior for LB Pharmaceuticals; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
50.16 (Aug 25)
1Y low
15.19 (Nov 21)
Last close
38.85

LBRX price performance

1 week

-9.67%

1 month

-0.97%

3 months

-18.42%

6 months

+38.16%

Year to date

+74.53%

1 year

+153.42%

LBRX price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day40.45Price below40.27Price below
10-day42.25Price below40.93Price below
20-day41.07Price below40.80Price below
50-day39.49Price below40.37Price below
100-day40.59Price below38.88Price below
200-day34.04Price above33.36Price above

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)42.26
Resistance 2 (R2)41.46
Resistance 1 (R1)40.16
Pivot point39.36
Support 1 (S1)38.06
Support 2 (S2)37.26
Support 3 (S3)35.96

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis